Logo image of CTOS

CUSTOM TRUCK ONE SOURCE INC (CTOS) Stock Fundamental Analysis

NYSE:CTOS - New York Stock Exchange, Inc. - US23204X1037 - Common Stock - Currency: USD

3.76  -0.04 (-1.05%)

After market: 3.76 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CTOS. CTOS was compared to 48 industry peers in the Trading Companies & Distributors industry. Both the profitability and financial health of CTOS have multiple concerns. CTOS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CTOS has reported negative net income.
CTOS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CTOS reported negative net income in multiple years.
Of the past 5 years CTOS 4 years had a positive operating cash flow.
CTOS Yearly Net Income VS EBIT VS OCF VS FCFCTOS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

CTOS has a Return On Assets of -0.82%. This is amonst the worse of the industry: CTOS underperforms 81.25% of its industry peers.
With a Return On Equity value of -3.33%, CTOS is not doing good in the industry: 81.25% of the companies in the same industry are doing better.
The Return On Invested Capital of CTOS (4.22%) is worse than 70.83% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CTOS is below the industry average of 9.25%.
Industry RankSector Rank
ROA -0.82%
ROE -3.33%
ROIC 4.22%
ROA(3y)0.67%
ROA(5y)-1.5%
ROE(3y)2.19%
ROE(5y)N/A
ROIC(3y)5.22%
ROIC(5y)3.81%
CTOS Yearly ROA, ROE, ROICCTOS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100 150 200

1.3 Margins

Looking at the Operating Margin, with a value of 6.70%, CTOS is in line with its industry, outperforming 47.92% of the companies in the same industry.
In the last couple of years the Operating Margin of CTOS has declined.
CTOS has a Gross Margin of 21.65%. This is in the lower half of the industry: CTOS underperforms 72.92% of its industry peers.
In the last couple of years the Gross Margin of CTOS has declined.
Industry RankSector Rank
OM 6.7%
PM (TTM) N/A
GM 21.65%
OM growth 3Y99.85%
OM growth 5Y-16.77%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.37%
GM growth 5Y-7.39%
CTOS Yearly Profit, Operating, Gross MarginsCTOS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

More info and screens

1

2. Health

2.1 Basic Checks

CTOS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
CTOS has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CTOS has more shares outstanding
CTOS has a better debt/assets ratio than last year.
CTOS Yearly Shares OutstandingCTOS Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CTOS Yearly Total Debt VS Total AssetsCTOS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 0.69, we must say that CTOS is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.69, CTOS is not doing good in the industry: 91.67% of the companies in the same industry are doing better.
CTOS has a Debt/Equity ratio of 1.76. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.76, CTOS is doing worse than 72.92% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.76
Debt/FCF N/A
Altman-Z 0.69
ROIC/WACC0.37
WACC11.39%
CTOS Yearly LT Debt VS Equity VS FCFCTOS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

CTOS has a Current Ratio of 1.30. This is a normal value and indicates that CTOS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.30, CTOS is doing worse than 75.00% of the companies in the same industry.
A Quick Ratio of 0.25 indicates that CTOS may have some problems paying its short term obligations.
CTOS has a worse Quick ratio (0.25) than 91.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 0.25
CTOS Yearly Current Assets VS Current LiabilitesCTOS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

4

3. Growth

3.1 Past

The earnings per share for CTOS have decreased strongly by -195.45% in the last year.
CTOS shows a decrease in Revenue. In the last year, the revenue decreased by -3.37%.
Measured over the past years, CTOS shows a very strong growth in Revenue. The Revenue has been growing by 46.84% on average per year.
EPS 1Y (TTM)-195.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-71.43%
Revenue 1Y (TTM)-3.37%
Revenue growth 3Y15.58%
Revenue growth 5Y46.84%
Sales Q2Q%-0.19%

3.2 Future

Based on estimates for the next years, CTOS will show a very strong growth in Earnings Per Share. The EPS will grow by 58.58% on average per year.
The Revenue is expected to grow by 6.52% on average over the next years.
EPS Next Y94.17%
EPS Next 2Y58.58%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.3%
Revenue Next 2Y7.58%
Revenue Next 3Y6.52%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CTOS Yearly Revenue VS EstimatesCTOS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
CTOS Yearly EPS VS EstimatesCTOS Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CTOS. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CTOS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CTOS Price Earnings VS Forward Price EarningsCTOS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CTOS indicates a rather cheap valuation: CTOS is cheaper than 81.25% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.68
CTOS Per share dataCTOS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

CTOS's earnings are expected to grow with 58.58% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y58.58%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CTOS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CUSTOM TRUCK ONE SOURCE INC

NYSE:CTOS (4/21/2025, 4:15:00 PM)

After market: 3.76 0 (0%)

3.76

-0.04 (-1.05%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)03-04 2025-03-04/amc
Earnings (Next)04-30 2025-04-30/amc
Inst Owners25.94%
Inst Owner Change0%
Ins Owners2.53%
Ins Owner Change12.15%
Market Cap848.44M
Analysts81.67
Price Target6.55 (74.2%)
Short Float %8.29%
Short Ratio6.1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-96.61%
Min EPS beat(2)-142.24%
Max EPS beat(2)-50.98%
EPS beat(4)0
Avg EPS beat(4)-266.75%
Min EPS beat(4)-553.59%
Max EPS beat(4)-50.98%
EPS beat(8)2
Avg EPS beat(8)-108.33%
EPS beat(12)5
Avg EPS beat(12)30.67%
EPS beat(16)6
Avg EPS beat(16)-145.16%
Revenue beat(2)0
Avg Revenue beat(2)-4.12%
Min Revenue beat(2)-6.04%
Max Revenue beat(2)-2.21%
Revenue beat(4)0
Avg Revenue beat(4)-7.36%
Min Revenue beat(4)-11.56%
Max Revenue beat(4)-2.21%
Revenue beat(8)4
Avg Revenue beat(8)1.2%
Revenue beat(12)6
Avg Revenue beat(12)0.76%
Revenue beat(16)8
Avg Revenue beat(16)0.76%
PT rev (1m)4.05%
PT rev (3m)4.05%
EPS NQ rev (1m)-14.29%
EPS NQ rev (3m)-89.45%
EPS NY rev (1m)-2.83%
EPS NY rev (3m)-190.02%
Revenue NQ rev (1m)0.58%
Revenue NQ rev (3m)1.32%
Revenue NY rev (1m)7.17%
Revenue NY rev (3m)6.77%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.47
P/FCF N/A
P/OCF 6.96
P/B 0.99
P/tB N/A
EV/EBITDA 6.68
EPS(TTM)-0.21
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-1.22
FCFYN/A
OCF(TTM)0.54
OCFY14.38%
SpS7.99
BVpS3.82
TBVpS-0.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.82%
ROE -3.33%
ROCE 4.83%
ROIC 4.22%
ROICexc 4.22%
ROICexgc 6.85%
OM 6.7%
PM (TTM) N/A
GM 21.65%
FCFM N/A
ROA(3y)0.67%
ROA(5y)-1.5%
ROE(3y)2.19%
ROE(5y)N/A
ROIC(3y)5.22%
ROIC(5y)3.81%
ROICexc(3y)5.24%
ROICexc(5y)3.82%
ROICexgc(3y)9%
ROICexgc(5y)6.62%
ROCE(3y)5.98%
ROCE(5y)4.36%
ROICexcg growth 3Y112.25%
ROICexcg growth 5Y-5.47%
ROICexc growth 3Y121.67%
ROICexc growth 5Y-4.41%
OM growth 3Y99.85%
OM growth 5Y-16.77%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.37%
GM growth 5Y-7.39%
F-Score4
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 1.76
Debt/FCF N/A
Debt/EBITDA 4.26
Cap/Depr 168.89%
Cap/Sales 22.1%
Interest Coverage 0.79
Cash Conversion 34.21%
Profit Quality N/A
Current Ratio 1.3
Quick Ratio 0.25
Altman-Z 0.69
F-Score4
WACC11.39%
ROIC/WACC0.37
Cap/Depr(3y)162.56%
Cap/Depr(5y)132.08%
Cap/Sales(3y)21.1%
Cap/Sales(5y)20.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-195.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-71.43%
EPS Next Y94.17%
EPS Next 2Y58.58%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.37%
Revenue growth 3Y15.58%
Revenue growth 5Y46.84%
Sales Q2Q%-0.19%
Revenue Next Year9.3%
Revenue Next 2Y7.58%
Revenue Next 3Y6.52%
Revenue Next 5YN/A
EBIT growth 1Y-34.78%
EBIT growth 3Y130.99%
EBIT growth 5Y22.21%
EBIT Next Year222.36%
EBIT Next 3Y55.51%
EBIT Next 5YN/A
FCF growth 1Y30.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y494.99%
OCF growth 3Y-4.24%
OCF growth 5Y45.35%